| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.034 | 0.9 |